4.7 Article

The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity

期刊

NATURE IMMUNOLOGY
卷 22, 期 4, 页码 460-+

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41590-021-00888-3

关键词

-

资金

  1. NIH/NCI [CA248430, CA217648, CA123088, CA099985, CA193136, CA152470]
  2. NIH through University of Michigan Rogel Cancer Center support grant [P30CA46592]

向作者/读者索取更多资源

The E3 ubiquitin ligase MDM2, known for inhibiting the tumor suppressor p53, also plays a T cell-intrinsic role that supports antitumor responses. Targeting the p53-MDM2 pathway with APG-115 enhances T cell immunity and synergizes with cancer immunotherapy, with effects dependent on p53 and MDM2 in T cells. This highlights a potential therapeutic strategy for treating cancer patients, regardless of tumor p53 status.
Targeting the p53-MDM2 pathway to reactivate tumor p53 is a chemotherapeutic approach. However, the involvement of this pathway in CD8(+) T cell-mediated antitumor immunity is unknown. Here, we report that mice with MDM2 deficiency in T cells exhibit accelerated tumor progression and a decrease in tumor-infiltrating CD8(+) T cell survival and function. Mechanistically, MDM2 competes with c-Cbl for STAT5 binding, reduces c-Cbl-mediated STAT5 degradation and enhances STAT5 stability in tumor-infiltrating CD8(+) T cells. Targeting the p53-MDM2 interaction with a pharmacological agent, APG-115, augmented MDM2 in T cells, thereby stabilizing STAT5, boosting T cell immunity and synergizing with cancer immunotherapy. Unexpectedly, these effects of APG-115 were dependent on p53 and MDM2 in T cells. Clinically, MDM2 abundance correlated with T cell function and interferon-gamma signature in patients with cancer. Thus, the p53-MDM2 pathway controls T cell immunity, and targeting this pathway may treat patients with cancer regardless of tumor p53 status. The E3 ubiquitin ligase MDM2 inhibits the tumor suppressor p53 and is an important therapeutic target. Zou and colleagues demonstrate that MDM2 also has a T cell-intrinsic role that supports antitumor responses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据